register

News & Trends - MedTech & Diagnostics

Patient voice amplifies the value of medtech, strengthening launch of new report at Parliament House

Health Industry Hub | June 20, 2023 |

MedTech & Diagnostics News: Australian patients could benefit from ground-breaking medical technologies sooner if the government implements reforms that were recommended by a House of Representatives inquiry over a year ago.

Ian Burgess, CEO of Medical Technology Association of Australia (MTAA) and Eden, an inspiring 17 year old, joined Health Industry Hub to discuss the transformative power of medtech. The interview highlighted the release of The Value of MedTech report, being launched at Parliament House tonight, that quantifies the substantial value that the medtech sector brings to Australia’s health system, economy, and most importantly, to patients.

“We wanted to provide an authoritative report that quantifies the enormous value that medtech provides to Australia,” Mr Burgess explained. “The report outlines and quantifies the contributions that med tech makes to our economy, health system, and patients every day. It also emphasises the opportunities to maximise future benefits and strengthen our health system and economy while providing great outcomes for patients.”

The conversation then shifted to Eden, who courageously shared his personal story and the decision to undergo surgery. Eden vividly described the challenges he faced due to severe pain from a rare spinal condition, impacting his daily activities and enjoyment of life as a teenager. After the recovery period, Eden’s life was completely transformed. He now experiences no pain, participates in powerlifting and mountain biking, and leads an active, pain-free lifestyle.

The interview then delved into the barriers identified in the report that pose challenges to the future growth of the medtech sector. Mr Burgess stressed the urgency of addressing these issues to prevent Australians from waiting longer than necessary for life-saving and life-changing technology. He called for a cultural shift from viewing healthcare as a short-term cost to recognising it as a long-term investment.

The MTAA is urging policymakers to recognise the broader value that medtech provides to patients and the economy and to ensure that assessment and approval processes align with this recognition.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.